Core Viewpoint - Halper Sadeh LLC is investigating the merger between VerifyMe, Inc. and Open World Ltd, focusing on potential violations of federal securities laws by VerifyMe and its board of directors [1] Group 1 - The investigation is aimed at determining the rights and options available to VerifyMe shareholders [1] - Halper Sadeh encourages shareholders to contact them for more information regarding the investigation [1]

Core Viewpoint - The law firm Halper Sadeh LLC is investigating the fairness of the sale of Amicus Therapeutics, Inc. to BioMarin Pharmaceutical Inc. at a price of $14.50 per share for Amicus shareholders [1]. Company Summary - Amicus Therapeutics, Inc. is being sold to BioMarin Pharmaceutical Inc. for $14.50 per share [1]. - The investigation by Halper Sadeh LLC focuses on whether this sale price is fair to Amicus shareholders [1]. Legal Rights and Options - Halper Sadeh encourages Amicus shareholders to learn more about their legal rights and options regarding the sale [1]. - Shareholders can contact Daniel Sadeh or Zachary Halper for further information [1].